Non-profit · founded 2003
Baruch S. Blumberg Institute
Doylestown, United States · blumberginstitute.org
- Citations, last 5 years
- 2 408
- Works, last 5 years
- 218
- h-index
- 123
- Scientists listed
- 0
- Grants since 2016
- 29
Grants received
2024–2025 · research · R21
Chemically ligated-guide RNA (lgRNA)-based CRISPR/Cas9 gene editing for elimination of hepatitis B virus cccDNA
Ju-Tao Guo · Baruch S. Blumberg Institute · funded by National Institutes of Health
2024–2027 · grant · BCRP
Novel Mechanisms Governing Human Breast Cancer Chromosomal Instability
Richard Pestell · Baruch S. Blumberg Institute · funded by Congressionally Directed Medical Research Programs
2024–2026 · research · R21
Chemically ligated-guide RNA (lgRNA)-based CRISPR/Cas9 gene editing for elimination of hepatitis B virus cccDNA
Ju-Tao Guo · Baruch S. Blumberg Institute · funded by National Institutes of Health
2023–2026 · research · R21
Liver Targeting Dihydroquinolizinone (DHQ) Molecules as Hepatitis B Virus Antivirals with Reduced Toxicity
Yanming Du · Baruch S. Blumberg Institute · funded by National Institutes of Health
2023–2028 · cooperative agreement · U01
Impact of preanalytic procurement and processing variables on the detection of HCC DNA in urine
Ying-Hsiu Su · Baruch S. Blumberg Institute · funded by National Institutes of Health
2023–2025 · research · R21
Liver Targeting Dihydroquinolizinone (DHQ) Molecules as Hepatitis B Virus Antivirals with Reduced Toxicity
Yanming Du · Baruch S. Blumberg Institute · funded by National Institutes of Health
2023–2028 · cooperative agreement · U01
Impact of preanalytic procurement and processing variables on the detection of HCC DNA in urine
Ying-Hsiu Su · Baruch S. Blumberg Institute · funded by National Institutes of Health
2023–2024 · grant · RCRP
Enhancing Natural Killer Cell Cytotoxicity Toward Cholangiocarcinoma
Ian Henrich · Baruch S. Blumberg Institute · funded by Congressionally Directed Medical Research Programs
2023–2028 · cooperative agreement · U01
Impact of preanalytic procurement and processing variables on the detection of HCC DNA in urine
Ying-Hsiu Su · Baruch S. Blumberg Institute · funded by National Institutes of Health
2022–2025 · contract · N01
Development of an Antiviral to Combat Viral Infections
Jinhong Chang · Baruch S. Blumberg Institute · funded by National Institutes of Health
2022–2023 · contract · N01
DEVELOPMENT OF AN ANTIVIRAL FOR YELLOW FEVER VIRUS INFECTION
Jinhong Chang · Baruch S. Blumberg Institute · funded by National Institutes of Health
2022–2025 · contract · N01
Development of an Antiviral for Yellow Fever Virus Infection
Jinhong Chang · Baruch S. Blumberg Institute · funded by National Institutes of Health
2021–2025 · grant · PRMRP
Mechanism of CpAM-Induced HBV Core Protein Degradation and Therapeutic Implication
Ju-Tao Guo · Baruch S. Blumberg Institute · funded by Congressionally Directed Medical Research Programs
2020–2022 · research · R21
CCR5 inhibitors to enhance therapeutic response of breast cancer to DNA damaging agents
Richard G Pestell · Baruch S. Blumberg Institute · funded by National Institutes of Health
2020–2025 · grant · BCRP
Development of Inhibitors of RAD52 Protein Against BRCA-Deficient Breast Cancer
Yanming Du · Baruch S. Blumberg Institute · funded by Congressionally Directed Medical Research Programs
2018–2023 · research · R01
Development of Benzodiazepine YFV NS4B inhibitors as therapeutic agents for Yellow Fever
Jinhong Chang · Baruch S. Blumberg Institute · funded by National Institutes of Health
2018–2022 · grant · BCRP
Novel Mechanisms Governing Human Breast Cancer Chromosomal Instability
Richard Pestell · Baruch S. Blumberg Institute · funded by Congressionally Directed Medical Research Programs
2018–2023 · research · R01
Development of Benzodiazepine YFV NS4B inhibitors as therapeutic agents for Yellow Fever
Jinhong Chang · Baruch S. Blumberg Institute · funded by National Institutes of Health
2018–2023 · research · R01
Development of Benzodiazepine YFV NS4B inhibitors as therapeutic agents for Yellow Fever
Jinhong Chang · Baruch S. Blumberg Institute · funded by National Institutes of Health
2018–2025 · research · R01
Development of Benzodiazepine YFV NS4B inhibitors as therapeutic agents for Yellow Fever
Jinhong Chang · Baruch S. Blumberg Institute · funded by National Institutes of Health
2018–2023 · research · R01
Development of Benzodiazepine YFV NS4B inhibitors as therapeutic agents for Yellow Fever
Jinhong Chang · Baruch S. Blumberg Institute · funded by National Institutes of Health
2017–2021 · grant · PRMRP
Molecular Mechanism of the Dual Effects of Capsid Assembly Effectors on HBV Capsid Assembly and Disassembly
Ju-Tao Guo · Baruch S. Blumberg Institute · funded by Congressionally Directed Medical Research Programs
2016–2022 · research · R01
Development of cell-free DNA assays for HCC screening and liquid biopsy
Ying-Hsiu Su · Baruch S. Blumberg Institute · funded by National Institutes of Health
2016–2021 · research · R01
Development of cell-free DNA assays for HCC screening and liquid biopsy
Ying-Hsiu Su · Baruch S. Blumberg Institute · funded by National Institutes of Health
2016–2021 · research · R01
Development of cell-free DNA assays for HCC screening and liquid biopsy
Ying-Hsiu Su · Baruch S. Blumberg Institute · funded by National Institutes of Health
2016–2021 · research · R01
Development of cell-free DNA assays for HCC screening and liquid biopsy
Ying-Hsiu Su · Baruch S. Blumberg Institute · funded by National Institutes of Health
2016–2021 · research · R01
Development of cell-free DNA assays for HCC screening and liquid biopsy
Ying-Hsiu Su · Baruch S. Blumberg Institute · funded by National Institutes of Health
2014–2020 · research · R01
Evaluation of therapeutic benefits of HBV nucleocapsid assembly inhibitors
Yanming Du · Baruch S. Blumberg Institute · funded by National Institutes of Health
2007–2020 · research · R01
DACH1/Eya Cell fate determination factor and mammary tumorigenesis
Richard G Pestell · Baruch S. Blumberg Institute · funded by National Institutes of Health